In Vivo Induced Antigen Technology (IVIAT) and Change Mediated Antigen Technology (CMAT)

Martin Handfield, Jeffrey Hillman

Open source

DOI
10.2174/187152606778249908
Published
2006-09-01
Container
Infectious Disorders - Drug Targets
Publisher
Bentham Science Publishers Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/187152606778249908,
  title = {In Vivo Induced Antigen Technology (IVIAT) and Change Mediated Antigen Technology (CMAT)},
  author = {Martin Handfield and Jeffrey Hillman},
  year = {2006},
  journal = {Infectious Disorders - Drug Targets},
  doi = {10.2174/187152606778249908},
  url = {https://doi.org/10.2174/187152606778249908}
}

RIS

TY  - JOUR
TI  - In Vivo Induced Antigen Technology (IVIAT) and Change Mediated Antigen Technology (CMAT)
AU  - Martin Handfield
AU  - Jeffrey Hillman
PY  - 2006
JO  - Infectious Disorders - Drug Targets
DO  - 10.2174/187152606778249908
UR  - https://doi.org/10.2174/187152606778249908
ER  - 

APA

Handfield, M., & Hillman, J. (2006). In Vivo Induced Antigen Technology (IVIAT) and Change Mediated Antigen Technology (CMAT). Infectious Disorders - Drug Targets. https://doi.org/10.2174/187152606778249908

Source records